封面
市場調查報告書
商品編碼
1477910

尿失禁治療設備市場規模 - 按產品(尿道吊帶、導管、電刺激裝置、人工尿道括約肌)、失禁(壓力、急迫、混合)、類別(內部、外部)、最終用途和預測,2024 - 2032 年

Urinary Incontinence Treatment Devices Market Size - By Product (Urethral Sling, Catheter, Electrical Stimulation Device, Artificial Urinary Sphincter), Incontinence (Stress, Urge, Mixed), Category (Internal, External), End-use & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

受全球人口老化、尿失禁治療設備技術進步以及人們對尿失禁及其治療方案認知不斷提高的推動,2024-2032年全球尿失禁治療設備市場將以8.6%的複合年成長率成長。

由於人口老化、生活方式改變和慢性疾病增加等因素,數百萬人受到尿失禁的影響,對先進治療解決方案的需求正在增加。根據 Medscape Emedicine 的數據,經常被忽視和低估的尿失禁隨著年齡的成長而變得更加普遍,影響了 38-55% 的 60 歲以上女性和 50-84% 的長期護理機構老年居民。盛行率的激增,加上人們對尿失禁及其併發症的認知不斷提高,正在推動創新治療設備的開發和採用。

人們正在尋求技術進步,包括微創手術和穿戴式解決方案,以滿足不同的患者需求。醫療保健提供者、研究機構和製造商之間的合作正在進一步提高治療效果。在有利的報銷政策和政府措施的支持下,尿失禁治療設備市場有望大幅擴張,為全球受影響的個人提供更好的生活品質。

尿失禁治療設備市場根據最終用戶、產品類型、類別、失禁和地區進行分類。

導管細分市場將在 2024 年至 2032 年期間獲得值得稱讚的牽引力,因為導管透過促進膀胱排空在控制尿失禁方面發揮至關重要的作用。隨著技術的進步,導管變得更加先進,提供抗菌塗層和改進材料等功能,以提高患者舒適度並降低感染風險,從而促進導管段的成長。

到 2032 年,終端用戶領域的診所將以顯著的複合年成長率擴張,因為診所為尿失禁患者提供專門護理和廣泛的治療選擇。門診手術的便利性和診所熟練的醫療保健專業人員的可用性使它們成為許多尋求尿失禁治療的患者的首選。

在中國、印度和日本等國家快速城市化、醫療基礎設施投資增加以及人口老化日益嚴重的推動下,亞太地區尿失禁治療設備產業將在 2032 年顯著擴張。此外,人們對尿失禁的認知不斷提高,醫療保健服務的普及預計將進一步推動該地區的產品需求。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 尿失禁(UI)盛行率增加
      • 設備和手術技術的技術進步
      • 攝護腺癌發生率不斷上升
    • 產業陷阱與挑戰
      • 程序成本高
      • 與手術相關的風險和併發症
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 定價分析
  • 未來市場趨勢
  • 報銷場景

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 尿道吊帶
    • 男吊帶
    • 女性/陰道吊帶
      • 經閉孔吊帶
      • 無張力陰道吊帶
      • 迷你吊帶
  • 導尿管
    • 留置導管
    • 間歇導管
    • 外部導管
  • 電刺激裝置
  • 人工尿道括約肌
  • 其他產品

第 6 章:市場估計與預測:按失禁類型,2018 年 - 2032 年

  • 主要趨勢
  • 壓力
  • 敦促
  • 混合
  • 其他失禁類型

第 7 章:市場估計與預測:按類別,2018 - 2032

  • 主要趨勢
  • 內部失禁裝置
  • 外部失禁裝置

第 8 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 診所
  • 門診手術中心
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • B Braun Melsungen AG
  • Caldera Medical Inc.
  • Coloplast A/S
  • ConvaTec Group plc
  • Hollister Incorporated
  • Medtronic plc
  • PROMEDON GmbH
  • Teleflex Incorporated
  • Zephyr Surgical Implants
簡介目錄
Product Code: 8190

Global Urinary Incontinence Treatment Devices Market will grow at 8.6% CAGR during 2024-2032, driven by the growing aging population worldwide, technological advancements in urinary incontinence treatment devices, and rising awareness about urinary incontinence and its treatment options.

With millions affected by urinary incontinence disorders attributed to factors like aging demographics, lifestyle changes, and rising chronic diseases, the demand for advanced treatment solutions is on the rise. As per Medscape Emedicine, urinary incontinence, often overlooked and underreported, becomes more prevalent with age, impacting 38-55% of women over 60 and 50-84% of elderly residents in long-term care facilities. This surge in prevalence, coupled with growing awareness about urinary incontinence and its complications, is fueling the development and adoption of innovative treatment devices.

Technological advancements, including minimally invasive procedures and wearable solutions, are being pursued to address diverse patient needs. Collaborative efforts between healthcare providers, research institutions, and manufacturers are further enhancing treatment efficacy. Supported by favorable reimbursement policies and government initiatives, the urinary incontinence treatment devices market is poised for significant expansion, offering improved quality of life for affected individuals worldwide.

The Urinary Incontinence Treatment Devices Market is classified based on end-user, product type, category, incontinence, and region.

The catheters segment will gain commendable traction over 2024-2032, as catheters play a vital role in managing urinary incontinence by facilitating the emptying of the bladder. With technological advancements, catheters have become more advanced, offering features such as anti-microbial coatings and improved materials for enhanced patient comfort and reduced risk of infection, thereby inducing segment growth.

Clinics from the end-user segment will expand at a noteworthy CAGR through 2032 as clinics offer specialized care and access to a wide range of treatment options for patients suffering from urinary incontinence. The convenience of outpatient procedures and the availability of skilled healthcare professionals in clinics make them a preferred choice for many patients seeking treatment for urinary incontinence.

Asia Pacific Urinary Incontinence Treatment Devices Industry will expand notably by 2032, driven by rapid urbanization, increasing healthcare infrastructure investments, and a growing aging population in countries such as China, India, and Japan. Moreover, rising awareness about urinary incontinence and improving access to healthcare services is expected to further boost product demand in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of urinary incontinence (UI)
      • 3.2.1.2 Technological advancements in devices and surgical techniques
      • 3.2.1.3 Growing incidence of prostate cancer
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High procedural cost
      • 3.2.2.2 Risks and complications associated with the procedures
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Pricing analysis
  • 3.9 Future market trends
  • 3.10 Reimbursement scenario

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Urethral slings
    • 5.2.1 Male slings
    • 5.2.2 Female/vaginal slings
      • 5.2.2.1 Transobturator slings
      • 5.2.2.2 Tension-free vaginal tape slings
      • 5.2.2.3 Mini-slings
  • 5.3 Urinary catheters
    • 5.3.1 Indwelling catheters
    • 5.3.2 Intermittent catheters
    • 5.3.3 External catheters
  • 5.4 Electrical stimulation devices
  • 5.5 Artificial urinary sphincters
  • 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Incontinence Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Stress
  • 6.3 Urge
  • 6.4 Mixed
  • 6.5 Other incontinence type

Chapter 7 Market Estimates and Forecast, By Category, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Internal incontinence devices
  • 7.3 External incontinence devices

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Becton, Dickinson and Company
  • 10.2 Boston Scientific Corporation
  • 10.3 B Braun Melsungen AG
  • 10.4 Caldera Medical Inc.
  • 10.5 Coloplast A/S
  • 10.6 ConvaTec Group plc
  • 10.7 Hollister Incorporated
  • 10.8 Medtronic plc
  • 10.9 PROMEDON GmbH
  • 10.10 Teleflex Incorporated
  • 10.11 Zephyr Surgical Implants